Telzir
Lexiva (US)
Active substance: Fosamprenavir
Manufacturer: GlaxoSmithKline (UK)
Extract from the prescribing information:
"Patients should be informed that LEXIVA is not a cure for HIV infection and that they may continue to develop opportunistic infections and other complications associated with HIV disease. The long-term effects of LEXIVA are unknown at this time. Patients should be told that there are currently no data demonstrating that therapy with LEXIVA can reduce the risk of transmitting HIV to others."
The above has been extracted from the Lexiva prescribing information on the GlaxoSmithKline webpages.